-
It’s possible to buy a perfectly good hearing aid through the Internet for $7.92, it turns out. Clearwater attorney Denis DeVlaming discovered that when…
-
The U.S. Food and Drug Administration has issued an alert for patients and health care providers, asking them to quarantine nasal-irrigation solutions…
-
In the latest attempt to stem an epidemic of opioid painkiller overdoses, the FDA tightened prescribing guidelines. The drugs should only be used for patients with severe pain when other treatments have failed, the agency says, not for moderate pain.
-
When an especially nasty intestinal bug threatened 86-year-old Billie Iverson, an unusual transplant saved her. The medical solution, still experimental, was to replace her dangerous digestive bacteria with a healthier mix of microbes.
-
Until he discovered e-cigarettes at a flea market, John Sweet had a two-pack-a-day habit. After trying the $50 product, he decided to quit smoking because…
-
The FDA's proposal would set a threshold of 10 parts per billion for inorganic arsenic in apple juice — the same standard used for drinking water. In 2011, a pair of investigations raised alarms about the levels of inorganic arsenic, a carcinogen, in the juice.
-
Five people burst into flames last year after spray-on sunscreen ignited on their skin. The manufacturer has recalled those sprays, but the Food and Drug Administration says sprays can still pose a fire risk because they include flammable chemicals. So spray carefully, or opt for a shirt.
-
Scientists have completed the first long-term study of children allergic to milk who were treated with an experimental therapy based on giving them small doses of the very food that made them sick. Three to five years after the treatment, some kids remained free of allergic symptoms. But for others, severe reactions to milk had resumed.
-
The Food and Drug Administration and the U.S. attorney's office in Colorado cracked down on more than 1,600 websites that the feds say are breaking the law in the way they're selling prescription drugs, some of them counterfeits.
-
The ruling may end the era of what are also called "reverse-payment" deals, in which the maker of a brand-name drug pays a maker of generic drugs to not produce a lower-priced version of their product. The Federal Trade Commission can challenge such deals in court, the justices say.